Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy.

Ghafoor, Azam; Hassan, Raffit

Ghafoor, Azam; Hassan, Raffit.

Afiliação

Ghafoor A; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Hassan R; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: hassanr@mail.nih.gov.

J Thorac Oncol ; 17(7): 862-864, 2022 07.

Article em En | MEDLINE | ID: mdl-35750452

Assuntos

Neoplasias Pulmonares; Mesotelioma Maligno; Mesotelioma; Neoplasias Pleurais; Biomarcadores; Biomarcadores Tumorais/genética; Humanos; Neoplasias Pulmonares/patologia; Mesotelioma/patologia; Neoplasias Pleurais/patologia; Proteínas Supressoras de Tumor/genética; Ubiquitina Tiolesterase/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Mesotelioma Maligno / Neoplasias Pulmonares / Mesotelioma Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google